/Investor DB

415 Capital — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Vesper Medicalvespermedical.comin𝕏May 2019

Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.

HealthtechMedical DevicesWayne, US

Bruce J. Shook(President and CEO)Monica Klos(Executive Officer)inNeil Hattangadi(Director)inPeter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)

Co-investorsNew Enterprise Associates (NEA)Gilde HealthcareLightstone VenturesVensana Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.